// App-Quantinova.ai

1876 : Effect of Discontinuation of Denosumab in Subjects with Rheumatoid Arthritis Treated with Glucocorticoids

Researchers

Presenter

  • Michele McDermott

Principal Investigators

  • Jonathan Adachi

  • Willem Lems

  • Nancy Lane

  • Piet Geusens

  • Peter Butler

  • Li Chen

  • Daria Crittenden

  • Robin Dore

  • Stanley Cohen

Medical Centers

  • University of Alabama, Birmingham, AL

  • Amgen Inc, Thousand Oaks, CA

  • McMaster University, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada

  • VU University Medical Center, Amsterdam, Netherlands

  • University of California, Davis Medical Center, Sacramento, CA

  • Maastricht University, Maastricht, Netherlands

  • Robin K Dore Inc, Tustin, CA

  • Metroplex Clinical Research Center, Dallas, TX,

Locations

  • United States

  • Canada

  • Netherlands

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Bone Mineral Density

Drug/Treatment

  • Glucocorticoid

  • Prednisone

  • Denosumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved